ENROfloxacin Chew Treat
ENROfloxacin is an FDA-approved preparation containing ENROfloxacin, for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
Veterinarians most commonly consider enrofloxacin when a patient is presented with complex respiratory infections, urinary tract infections or deep skin infections. It is also a frequent point of discussion in the management of prostate infections and certain infections of the ear, as the medication is characterized by its ability to penetrate a wide range of body tissues. Due to its broad spectrum of activity, your veterinarian may select this medication for patients where other antimicrobial classes have been excluded based on diagnostic findings.At a pharmacological level, enrofloxacin acts as a bactericidal agent by inhibiting the bacterial enzyme DNA gyrase. This enzyme is essential for the replication and transcription of bacterial DNA; by blocking its function, enrofloxacin is understood to inhibit the bacteria from successfully dividing and maintaining their genetic material, leading to cell death. Enrofloxacin is partially metabolized in the liver to ciprofloxacin, another active antimicrobial, which contributes to its overall clinical profile. Your veterinarian will determine the appropriate dose and administration route based on the species, weight and specific diagnostic culture results of your pet.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of enrofloxacin include gastrointestinal changes such as decreased appetite, vomiting or loose stools. In cats, a significant clinical consideration involves the potential for retinal changes or vision health concerns associated with higher doses; your veterinarian will weigh this carefully when designing a protocol for feline patients. Additionally, in young, rapidly growing animals—particularly large breed dogs—enrofloxacin has been discussed in the context of articular cartilage abnormalities and its use is typically avoided during certain stages of skeletal development.
This medication is typically used with caution or avoided in patients with known seizure disorders, as fluoroquinolones can influence the central nervous system threshold. It is also carefully evaluated in patients with pre-existing kidney or liver impairment, as these organs are responsible for the metabolic processing and elimination of the medication. Enrofloxacin can interact with certain minerals such as calcium, iron or aluminum, which may interfere with its absorption; therefore, your veterinarian may suggest specific timing if your pet receives oral supplements or antacids. Ensure your veterinarian has a complete history of all other prescriptions your pet is receiving before starting therapy. Contact your veterinarian promptly if you observe significant lethargy, behavioral changes or signs of an allergic reaction.
Yes. Enrofloxacin is a prescription antimicrobial and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all prescriptions before any medication is prepared or shipped to your home.
Yes. While enrofloxacin is available in various commercial tablet and injectable formats, Mixlab can compound this medication into specialized strengths or flavored dosage forms—such as oral suspensions, gourmeds or topical preparations—if your veterinarian determines a customized preparation is necessary. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians consider age a critical factor because enrofloxacin has been associated with damage to the articular cartilage in growing animals. This risk is most frequently discussed in large or giant breed puppies during their primary growth phases, leading veterinarians to typically select alternative medications for these patients.
In feline patients, veterinarians monitor specifically for retinal toxicity, which can occur at higher doses or in patients with impaired elimination. Your veterinarian will determine the appropriate dose for your cat to maintain a profile that balances clinical needs with the safety of their vision.
